P276 LOW RISK FOR DEVELOPING AUTOANTIBODIES AND AUTOIMMUNE DISORDERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES ON LONG TERM TREATMENT WITH INFLIXIMAB

✍ Scribed by G.J. Mantzaris; S. Ballas; A. Roussos; S. Koilakou; A. Christidou; C. Kalantzis; E. Grivas; N. Apostolou; N. Kanellopoulos; K. Papamichail; G. Agalos; A. Tsirogianni; N. Kalantzis; A. Nakos; A. Archimandritis

• Book ID: 119637473
• Publisher: Oxford University Press
• Year: 2008
• Weight: 67 KB
• Volume: 2
• Category: Article
• ISSN: 1873-9954
• DOI: 10.1016/s1873-9954(08)70287-8